Medtronic PLC
MDT93.480USD
-0.550-0.58%
Cierre 09/15, 16:00（ET）Cotizaciones retrasadas 15 min
119.83BCap. mercado
25.71P/E TTM
Más Datos de Medtronic PLC Compañía
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Información de la empresa
Símbolo de cotizaciónMDT
Nombre de la empresaMedtronic PLC
Fecha de salida a bolsaNov 21, 1977
Director ejecutivoMr. Geoffrey S. (Geoff) Martha
Número de empleados95000
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 21
DirecciónBuilding Two Parkmore Business Park West
CiudadDUBLIN
Bolsa de valoresNYSE Consolidated
PaísIreland
Código postalH91 4K49
Teléfono1135314381700
Sitio Webhttps://www.medtronic.com/
Símbolo de cotizaciónMDT
Fecha de salida a bolsaNov 21, 1977
Director ejecutivoMr. Geoffrey S. (Geoff) Martha
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Enterprise Operations
Executive Vice President - Enterprise Operations
186.13K
+56.07%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+0.89%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+0.41%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+0.89%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Enterprise Operations
Executive Vice President - Enterprise Operations
186.13K
+56.07%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Surgical & Endoscopy
6.50B
19.38%
Cardiac Rhythm & Heart Failure
6.39B
19.06%
Cranial & Spinal Technologies
4.97B
14.83%
Coronary & Peripheral Vascular
3.55B
10.60%
Specialty Therapies
2.94B
8.77%
Otro
9.18B
27.37%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
17.17B
51.20%
Rest of World
16.25B
48.45%
Ireland
116.00M
0.35%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Surgical & Endoscopy
6.50B
19.38%
Cardiac Rhythm & Heart Failure
6.39B
19.06%
Cranial & Spinal Technologies
4.97B
14.83%
Coronary & Peripheral Vascular
3.55B
10.60%
Specialty Therapies
2.94B
8.77%
Otro
9.18B
27.37%
Estadísticas de accionistas
Actualizado: vie., 15 de ago
Actualizado: vie., 15 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.85%
BlackRock Institutional Trust Company, N.A.
5.29%
State Street Global Advisors (US)
4.66%
Capital Research Global Investors
2.83%
Geode Capital Management, L.L.C.
2.20%
Otro
75.16%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.85%
BlackRock Institutional Trust Company, N.A.
5.29%
State Street Global Advisors (US)
4.66%
Capital Research Global Investors
2.83%
Geode Capital Management, L.L.C.
2.20%
Otro
75.16%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
45.04%
Investment Advisor/Hedge Fund
29.11%
Research Firm
4.61%
Pension Fund
2.28%
Hedge Fund
2.25%
Bank and Trust
2.05%
Sovereign Wealth Fund
1.37%
Insurance Company
0.37%
Individual Investor
0.29%
Otro
12.63%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
2023Q1
3738
1.14B
85.40%
-14.71M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
124.44M
9.71%
+807.51K
+0.65%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
68.93M
5.38%
+886.72K
+1.30%
Mar 31, 2025
State Street Global Advisors (US)
60.04M
4.69%
-392.70K
-0.65%
Mar 31, 2025
Capital Research Global Investors
41.57M
3.24%
+8.36M
+25.19%
Mar 31, 2025
Geode Capital Management, L.L.C.
27.92M
2.18%
+860.11K
+3.18%
Mar 31, 2025
JP Morgan Asset Management
27.99M
2.18%
+3.65M
+15.02%
Mar 31, 2025
MFS Investment Management
20.60M
1.61%
+1.37M
+7.14%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
14.57M
1.14%
-1.01M
-6.49%
Dec 31, 2024
BlackRock Financial Management, Inc.
14.15M
1.1%
+923.56K
+6.99%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
Madison Covered Call ETF
2.98%
SPDR S&P Health Care Equipment ETF
2%
Direxion Daily Healthcare Bull 3X Shares
1.89%
iShares Advantage Large Cap Income ETF
0.92%
T Rowe Price Equity Income ETF
0.87%
SPDR Global Dow ETF
0.64%
Neuberger Berman Core Equity ETF
0.64%
JPMorgan US Value Factor ETF
0.51%
Wahed FTSE USA Shariah ETF
0.49%
Goldman Sachs Innovate Equity ETF
0.47%
Ver más
Madison Covered Call ETF
Proporción2.98%
SPDR S&P Health Care Equipment ETF
Proporción2%
Direxion Daily Healthcare Bull 3X Shares
Proporción1.89%
iShares Advantage Large Cap Income ETF
Proporción0.92%
T Rowe Price Equity Income ETF
Proporción0.87%
SPDR Global Dow ETF
Proporción0.64%
Neuberger Berman Core Equity ETF
Proporción0.64%
JPMorgan US Value Factor ETF
Proporción0.51%
Wahed FTSE USA Shariah ETF
Proporción0.49%
Goldman Sachs Innovate Equity ETF
Proporción0.47%
Dividendos
Un total de
17.37B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Mar 02, 2023
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023
Mar 24, 2023
Apr 14, 2023
Mar 23, 2023
Dec 08, 2022
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022
Dec 21, 2022
Jan 13, 2023
Dec 20, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
